An Observational Study For Ambrisentan

CompletedOBSERVATIONAL
Enrollment

800

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

July 31, 2013

Study Completion Date

July 31, 2013

Conditions
Hypertension, Pulmonary
Interventions
DRUG

ambrisentan

ambrisentan

Trial Locations (112)

1070

GSK Investigational Site, Brussels

2010

GSK Investigational Site, Darlinghurst

3000

GSK Investigational Site, Leuven

3004

GSK Investigational Site, Melbourne

4032

GSK Investigational Site, Chermside

5021

GSK Investigational Site, Bergen

10043

GSK Investigational Site, Orbassano (TO)

10117

GSK Investigational Site, Berlin

12559

GSK Investigational Site, Berlin

12683

GSK Investigational Site, Berlin

13385

GSK Investigational Site, Marseille

13915

GSK Investigational Site, Marseille

14004

GSK Investigational Site, Córdoba

14033

GSK Investigational Site, Caen

14929

GSK Investigational Site, Treuenbrietzen

17487

GSK Investigational Site, Greifswald

20246

GSK Investigational Site, Hamburg

22927

GSK Investigational Site, Großhansdorf

23538

GSK Investigational Site, Lübeck

25030

GSK Investigational Site, Besançon

27100

GSK Investigational Site, Pavia

28034

GSK Investigational Site, Madrid

28041

GSK Investigational Site, Madrid

29010

GSK Investigational Site, Málaga

29200

GSK Investigational Site, Brest

30625

GSK Investigational Site, Hanover

31059

GSK Investigational Site, Toulouse

32005

GSK Investigational Site, Ourense

33000

GSK Investigational Site, Bordeaux

33604

GSK Investigational Site, Pessac

34295

GSK Investigational Site, Montpellier

35033

GSK Investigational Site, Rennes

35392

GSK Investigational Site, Giessen

36071

GSK Investigational Site, Pontevedra

37044

GSK Investigational Site, Tours

38043

GSK Investigational Site, Grenoble

40138

GSK Investigational Site, Bologna

41013

GSK Investigational Site, Seville

42699

GSK Investigational Site, Solingen

44093

GSK Investigational Site, Nantes

45004

GSK Investigational Site, Toledo

45122

GSK Investigational Site, Essen

46026

GSK Investigational Site, Valencia

47441

GSK Investigational Site, Moers

50139

GSK Investigational Site, Florence

50937

GSK Investigational Site, Cologne

51092

GSK Investigational Site, Reims

52074

GSK Investigational Site, Aachen

54511

GSK Investigational Site, Vandœuvre-lès-Nancy

55131

GSK Investigational Site, Mainz

56124

GSK Investigational Site, Pisa

57010

GSK Investigational Site, Thessaloniki

59037

GSK Investigational Site, Lille

67098

GSK Investigational Site, Strasbourg

68100

GSK Investigational Site, Alexandroupoli

68167

GSK Investigational Site, Mannheim

69120

GSK Investigational Site, Heidelberg

69126

GSK Investigational Site, Heidelberg

69677

GSK Investigational Site, Bron

70839

GSK Investigational Site, Gerlingen

74245

GSK Investigational Site, Löwenstein

76031

GSK Investigational Site, Rouen

78166

GSK Investigational Site, Donaueschingen

79106

GSK Investigational Site, Freiburg im Breisgau

80131

GSK Investigational Site, Napoli

81377

GSK Investigational Site, Munich

86021

GSK Investigational Site, Poitiers

89081

GSK Investigational Site, Ulm

90127

GSK Investigational Site, Palermo

92140

GSK Investigational Site, Clamart

93053

GSK Investigational Site, Regensburg

95100

GSK Investigational Site, Catania

T6G 2B7

GSK Investigational Site, Edmonton

V5Z 1M9

GSK Investigational Site, Vancouver

R3A 1R8

GSK Investigational Site, Winnipeg

B3H 3A7

GSK Investigational Site, Halifax

N6A 5W9

GSK Investigational Site, London

M5G 2N2

GSK Investigational Site, Toronto

H3T 1E2

GSK Investigational Site, Montreal

128 08

GSK Investigational Site, Prague

140 00

GSK Investigational Site, Prague

DK-8200

GSK Investigational Site, Aarhus N

03048

GSK Investigational Site, Cottbus

01307

GSK Investigational Site, Dresden

04103

GSK Investigational Site, Leipzig

124 62

GSK Investigational Site, Athens

546 36

GSK Investigational Site, Thessaloniki

166 73

GSK Investigational Site, Voula / Athens

00161

GSK Investigational Site, Rome

1081 HV

GSK Investigational Site, Amsterdam

1105 AZ

GSK Investigational Site, Amsterdam

9713 GZ

GSK Investigational Site, Groningen

6229 HX

GSK Investigational Site, Maastricht

3435 CM

GSK Investigational Site, Nieuwegein

6525 GA

GSK Investigational Site, Nijmegen

3015 CE

GSK Investigational Site, Rotterdam

0027

GSK Investigational Site, Oslo

833 48

GSK Investigational Site, Bratislava

040 11

GSK Investigational Site, Košice

08035

GSK Investigational Site, Barcelona

08036

GSK Investigational Site, Barcelona

SE-413 45

GSK Investigational Site, Gothenburg

SE-581 85

GSK Investigational Site, Linköping

SE-221 85

GSK Investigational Site, Lund

SE-901 85

GSK Investigational Site, Umeå

SE-751 85

GSK Investigational Site, Uppsala

CB3 8RE

GSK Investigational Site, Cambridge

G81 4DY

GSK Investigational Site, Clydebank

NW3 2QG

GSK Investigational Site, London

W12 0HS

GSK Investigational Site, London

NE7 7DN

GSK Investigational Site, Newcastle upon Tyne

S10 2JF

GSK Investigational Site, Sheffield

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT00679224 - An Observational Study For Ambrisentan | Biotech Hunter | Biotech Hunter